En1 Farma Chemist & Druggist Llp - Company Profile

It is a home appliances limited liability partnership based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About En1 Farma Chemist & Druggist Llp

En1 Farma Chemist & Druggist Llp, a active limited liability partnership, was established on 04 January 2019 in Mumbai, Maharashtra, India. Engaging in retailers within the home appliances sector, it holds LLPIN: AAN-9442. Registered under ROC Roc Mumbai I. It has total obligation of contribution of ₹25.00 K .

Its leadership includes Ajit Manohar Naik (Designated Partner), Ganesh Suresh Sarjine (Designated Partner). Past directors included Tausif Siraj Shaikh. Its latest date of accounts and solvency statement 31 March 2024. It is based at D-510, 5Th Floor, Kanakia Zillion, Lbs Marg, Nr Kurla Bus Depot,Kurla,, Mumbai, Maharashtra, 400070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAN-9442

  • Incorporation Date

    04 January 2019

  • Total Obligation of Contribution

    ₹25.00 K

  • ROC Code

    Roc Mumbai I

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 25.00 K
  • Company Age 7 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
Company report

En1 Farma Chemist & Druggist Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into En1 Farma Chemist & Druggist Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at En1 Farma Chemist & Druggist Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ajit Manohar Naik Designated Partner 04 Jan 2019 Current
Ganesh Suresh Sarjine Designated Partner 23 Nov 2022 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of En1 Farma Chemist & Druggist Llp.

Enhance accessibility to En1 Farma Chemist & Druggist Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

En1 Farma Chemist & Druggist Llp revenue growth over time
En1 Farma Chemist & Druggist Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of En1 Farma Chemist & Druggist Llp?

Unlock access to En1 Farma Chemist & Druggist Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at En1 Farma Chemist & Druggist Llp?

Unlock and access historical data on people associated with En1 Farma Chemist & Druggist Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of En1 Farma Chemist & Druggist Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped En1 Farma Chemist & Druggist Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on En1 Farma Chemist & Druggist Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on En1 Farma Chemist & Druggist Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity En1 Farma Chemist & Druggist Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I. was completed.

  • Director Appointment

    Ganesh Suresh Sarjine was appointed as a Designated Partner was appointed as a Designated Partner on 23 Nov 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Director Appointment

    Ajit Manohar Naik was appointed as a Designated Partner was appointed as a Designated Partner on 04 Jan 2019 & has been associated with this company since 7 years 2 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on En1 Farma Chemist & Druggist Llp was registered on 04 Jan 2019 with Roc Mumbai I & aged 7 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of En1 Farma Chemist & Druggist Llp?

The LLPIN of En1 Farma Chemist & Druggist Llp is AAN-9442.

Where is En1 Farma Chemist & Druggist Llp headquartered?

En1 Farma Chemist & Druggist Llp is headquartered at D-510, 5Th Floor, Kanakia Zillion, Lbs Marg, Nr Kurla Bus Depot,Kurla,, Mumbai, Maharashtra, 400070.

When was En1 Farma Chemist & Druggist Llp incorporated?

En1 Farma Chemist & Druggist Llp was incorporated on 04 January 2019.

Who are the current directors of En1 Farma Chemist & Druggist Llp?

The current directors of En1 Farma Chemist & Druggist Llp are

What is the primary industry of En1 Farma Chemist & Druggist Llp?

The primary industry of En1 Farma Chemist & Druggist Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available